Literature DB >> 33126999

Current Approaches to the Pharmacologic Treatment of Core Symptoms Across the Lifespan of Autism Spectrum Disorder.

Gahan Pandina1, Robert H Ring2, Abigail Bangerter3, Seth Ness3.   

Abstract

There are no approved medications for autism spectrum disorder (ASD) core symptoms. However, given the significant clinical need, children and adults with ASD are prescribed medication off label for core or associated conditions, sometimes based on limited evidence for effectiveness. Recent developments in the understanding of biologic basis of ASD have led to novel targets with potential to impact core symptoms, and several clinical trials are underway. Heterogeneity in course of development, co-occurring conditions, and age-related treatment response variability hampers study outcomes. Novel measures and approaches to ASD clinical trial design will help in development of effective pharmacologic treatments.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  ASD; Autism; Clinical trials; Drug development; Therapeutics

Year:  2020        PMID: 33126999     DOI: 10.1016/j.psc.2020.08.003

Source DB:  PubMed          Journal:  Psychiatr Clin North Am        ISSN: 0193-953X


  2 in total

1.  Pharmacological and dietary-supplement treatments for autism spectrum disorder: a systematic review and network meta-analysis.

Authors:  Spyridon Siafis; Oğulcan Çıray; Hui Wu; Johannes Schneider-Thoma; Irene Bighelli; Marc Krause; Alessandro Rodolico; Anna Ceraso; Giacomo Deste; Maximilian Huhn; David Fraguas; Antonia San José Cáceres; Dimitris Mavridis; Tony Charman; Declan G Murphy; Mara Parellada; Celso Arango; Stefan Leucht
Journal:  Mol Autism       Date:  2022-03-04       Impact factor: 7.509

Review 2.  Autism Spectrum Disorder: Focus on Glutamatergic Neurotransmission.

Authors:  Martina Montanari; Giuseppina Martella; Paola Bonsi; Maria Meringolo
Journal:  Int J Mol Sci       Date:  2022-03-31       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.